Example: Heart Attack

Search clinical trials for: Romidepsin

Total 101 results

NCT01913119

Completed

A Pilot Study of Romidepsin in Relapsed or Refractory Extranodal NK/T-cell Lymphoma

Conditions: Histologically Proven Extranodal NKTcell Lymphoma
NCT04233697

Withdrawn

Copanlisib in Combination With Romidepsin in Patients With Relapsed or Refractory Mature T-cell Lymphoma

Conditions: Lymphoma, T-Cell
NCT03355768

Withdrawn

Romidepsin Versus Combination of Romidepsin Plus Pralatrexate in PTCL

Conditions: Lymphoma, T-Cell, Peripheral
NCT01353664

Completed

A Rollover Study for Patients Who Participated in Other Romidepsin Protocols

Conditions: Lymphoma; Cancer
NCT03547700

Active, not recruiting

Study of Ixazomib and Romidepsin in Peripheral T-cell Lymphoma (PTCL)

Conditions: Lymphoma, T-Cell, Peripheral
NCT00426764

Completed

A Trial of Romidepsin for Progressive or Relapsed Peripheral T-cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT02296398

Completed

Long-term Use of Romidepsin in Patients With CTCL

Conditions: Cutaneous T-cell Lymphoma
NCT01822886

Completed

Phase II Study of Gemcitabine+Romidepsin in the Relapsed/Refractory Peripheral T-cell Lymphoma Patients

Conditions: Peripheral T-cell Lymphoma
NCT03770000

Active, not recruiting

Safety and Efficacy of Tenalisib (RP6530) in Combination With Romidepsin in Patients With Relapsed/Refractory T-cell Lymphoma

Conditions: T Cell Lymphoma
NCT01324310

Completed

Influence of Ketoconazole on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Conditions: Hematologic Malignancy; Malignant Lymphoma
NCT02203578

Terminated

Romidepsin in Treating Patients With Steroid-Refractory Graft-versus-Host Disease

Conditions: Graft Versus Host Disease
NCT00765102

Terminated

Trial of Romidepsin and Bortezomib for Multiple Myeloma

Conditions: Multiple Myeloma
NCT01537744

Completed

A Trial of Oral 5-azacitidine in Combination With Romidepsin in Advanced Solid Tumors, With an Expansion Cohort in Virally Mediated Cancers and Liposarcoma

Conditions: Solid Tumors; Virally Mediated Cancers and Liposarcoma
NCT01324323

Completed

Influence of Rifampin on the Pharmacokinetics of Romidepsin in Patients With Advanced Cancer

Conditions: Hematologic Malignancy; Malignant Lymphoma
NCT01755975

Active, not recruiting

Romidepsin in Combination With Lenalidomide in Adults With Relapsed or Refractory Lymphomas and Myeloma

Conditions: Multiple Myeloma; Non-Hodgkin's Lymphoma
NCT01456039

Completed

A Japanese Phase 1/2 Study to Assess the Efficacy, Safety and Pharmacokinetics of Romidepsin in Patients With Peripheral T-cell Lymphoma (PTCL)

Conditions: Lymphoma, T-cell, Peripheral
NCT02850016

Completed

Romidepsin Plus 3BNC117 Phase 2a Study

Conditions: Human Immunodeficiency Virus (HIV)
NCT02616874

Completed

Study to Evaluate the Safety and Effect of HIVconsv Vaccines in Combination With Histone Deacetylase Inhibitor Romidepsin on the Viral Rebound Kinetic After Treatment Interruption in Early Treated HIV-1 Infected Individuals

Conditions: HIV
NCT00112463

Completed

Depsipeptide (Romidepsin) in Treating Patients With Metastatic or Unresectable Soft Tissue Sarcoma

Conditions: Adult Alveolar Soft-part Sarcoma; Adult Angiosarcoma; Adult Epithelioid Sarcoma; Adult Extraskeletal Chondrosarcoma; Adult Extraskeletal Osteosarcoma; Adult Fibrosarcoma; Adult Leiomyosarcoma; Adult Liposarcoma; Adult Malignant Fibrous Histiocytoma; Adult Malignant Hemangiopericytoma; Adult Malignant Mesenchymoma; Adult Neurofibrosarcoma; Adult Rhabdomyosarcoma; Adult Synovial Sarcoma; Gastrointestinal Stromal Tumor; Metastatic Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Recurrent Adult Soft Tissue Sarcoma; Recurrent Ewing Sarcoma/Peripheral Primitive Neuroectodermal Tumor; Stage III Adult Soft Tissue Sarcoma; Stage IV Adult Soft Tissue Sarcoma
NCT00091195

Terminated

Depsipeptide (Romidepsin) in Treating Patients With Recurrent Ovarian Epithelial or Peritoneal Cavity Cancer

Conditions: Primary Peritoneal Cavity Cancer; Recurrent Ovarian Epithelial Cancer
NCT00106418

Completed

A Research Study for Patients With Prostate Cancer

Conditions: Prostate Cancer; Metastases
NCT03742921

Recruiting

ISTODAX® for Intravenous Infusion Drug Use Results Survey- Relapsed or Refractory Peripheral T-Cell Lymphoma

Conditions: Lymphoma, T-Cell, Peripheral
NCT00963274

Completed

Bortezomib and Romidepsin in Patients With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Conditions: Leukemia; Lymphoma
NCT01796002

Active, not recruiting

Efficacy and Safety of Romidepsin CHOP vs CHOP in Patients With Untreated Peripheral T-Cell Lymphoma

Conditions: Peripheral T-cell Lymphoma
NCT01938833

Terminated

Romidepsin and Abraxane in Treating Patients With Metastatic Inflammatory Breast Cancer

Conditions: HER2-negative Breast Cancer; Inflammatory Breast Cancer; Male Breast Cancer; Recurrent Breast Cancer; Stage IV Breast Cancer